# Discriminator report

## Scenario echo
Human pancreas, with celltype, age, sex, and condition unspecified; notes are null. The embedding therefore should cover the baseline human pancreatic tissue landscape: endocrine islet cells, exocrine acinar and ductal epithelium, vascular and lymphatic endothelium, fibroblast/stellate and mural stromal cells, resident/trafficking immune cells, neural/Schwann cells, mesothelium/capsule, adipocytes, and generic cell-cycle state where present.

## Rating: minor
The blueprint is biologically plausible overall and has broad coverage of the human pancreas. It needs targeted refinement of a few mixed marker modules and modest resolution improvements, but the main structure is sound.

## Findings

### Minor issues
- **module:b_plasma_cell / axis:immune_b_plasma_cell** — The module mixes canonical B-cell genes (`MS4A1`, `CD79A`, `CD79B`, `BANK1`) with plasma-cell genes (`JCHAIN`, `MZB1`, `XBP1`) while a separate `plasma_cell` module and axis already exist. This makes the B/plasma axis redundant and less clean for distinguishing B cells from plasma cells.
  *Fix:* Edit `b_plasma_cell` into a B-cell-only module, for example retaining `MS4A1`, `CD79A`, `CD79B`, `CD74`, `BANK1` and adding B-lineage markers such as `CD37`, `CD22`, `CD19`, `MS4A6A` or similar literature-supported choices. Keep `plasma_cell` as the separate antibody-secreting program.

- **module:t_nk_lymphocyte / axes:immune_t_nk_lymphocyte and immune_nk_cell** — `t_nk_lymphocyte` combines TCR/CD3 genes with cytotoxic NK genes (`NKG7`, `GNLY`, `PRF1`), while `nk_cell` is separate. Because the gated T/NK axis is contrasted against the NK module, the positive module should not itself contain strong NK/cytotoxic markers.
  *Fix:* Make `t_nk_lymphocyte` a T-cell-focused module using TCR/CD3 genes plus T-cell markers such as `CD2`, `CD7`, `IL7R`, `CD4`, `CD8A` or `TRAC/TRBC1`, and move/retain cytotoxic genes in the NK module if needed.

- **module:mural_pericyte_smooth_muscle / axis:mural_vs_fibroblast_stellate** — Pericytes and vascular smooth muscle are expected stromal/vascular populations in pancreas, but the current module merges pericyte markers (`RGS5`, `PDGFRB`, `CSPG4`, `NOTCH3`, `MCAM`) with smooth-muscle markers (`ACTA2`, `TAGLN`, `MYH11`). The broad mural axis is plausible, but it does not resolve these two biologically distinct mural states.
  *Fix:* Add a pericyte-versus-smooth-muscle refinement axis, or split the current mural signal into supported pericyte and vascular smooth muscle modules while preserving the fibroblast/stellate distinction.

- **module:lymphatic_endothelial** — The lymphatic axis has canonical anchors (`PROX1`, `PDPN`, `CCL21`) but omits several common lymphatic endothelial markers and includes less immediately canonical choices such as `NTS`, `NRG3`, and `SEMA3D`. This is not clearly wrong, but it is weaker than the other endothelial modules.
  *Fix:* Strengthen the module with canonical human lymphatic markers such as `LYVE1`, `FLT4`, `MMRN1`, `RELN`, or `TFF3` if supported by the declared pancreas endothelial/atlas resources; keep any pancreas-specific genes only if they are well grounded.

- **ductal/centroacinar coverage** — The blueprint has one ductal bicarbonate/mucin module and a ductal-versus-acinar contrast, which covers main duct identity. It does not explicitly resolve centroacinar/intercalated duct-like cells, an expected pancreatic epithelial population often close to ductal/acinar boundaries.
  *Fix:* If supported by the available human pancreas literature resources, add a small ductal/centroacinar refinement axis or broaden the ductal module with carefully chosen markers that preserve this compartment without importing disease-associated ductal programs.

## Out of scope (FYI, not actionable for the Generator)
- I did not verify citation DOI accuracy or whether each cited paper contains each exact gene list; that is outside this discriminator pass.

## Summary for the next round
Focus on cleaning the immune compartment so B cells, plasma cells, T cells, and NK cells are separated by non-overlapping marker logic, then consider adding modest mural and ductal/centroacinar resolution. The current endocrine, acinar, ductal, stromal, endothelial, immune, neural, adipocyte, and cycling coverage is otherwise broadly appropriate for healthy human pancreas.
